Goldman Sachs, Morgan Stanley, Lehman Brothers and UBS are underwriting the initial public offering by oil giant BP of its petrochemical business, Innovene. The New York Stock Exchange float could raise up to $1bn (€813m).

The banks were disclosed in a preliminary prospectus filed yesterday with the US Securities and Exchange Commission. BP has not yet disclosed how many shares it plans to sell, nor has it set a price range.